TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Vera Brinks
Director, Pharmaceutics at ProQR Therapeutics

Profile

Vera Brinks received her PhD in 2009 in the field of biopharmaceutics at the Leiden University (The Netherlands). She is currently director pharmaceutics at ProQR Therapeutics, based in Leiden. Before joining ProQR 5 years ago, Vera has worked as postdoctoral fellow at the FDA (CDER, DTP), and as postdoctoral researcher at the Utrecht University (the Netherlands) for 6 years. She has over 25 publications in the field of therapeutic proteins, biosimilars and formulation-related quality attributes.

Vera Brinks's Network

Agenda Sessions

  • Oligonucleotide Drug Product (Development) for (Ultra) Orphan Ophthalmic Diseases

    , 14:15